ANKET
LIVE

Serial Number

97085429

Owner

Innate Pharma

Attorney

Corey K. Cho

Filing Date

Oct 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ANKET Trademark

Serial Number: 97085429 • Registration: 6952905

ANKET is a trademark filed by Innate Pharma on October 21, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Innate Pharma (3 trademarks)

117 avenue de Luminy

Entity Type: 33

Trademark Details

Filing Date

October 21, 2021

Registration Date

January 17, 2023

Published for Opposition

November 1, 2022

Goods & Services

Pharmaceuticals, medical, biological or biochemical preparations, substances for the treatment of diseases, as well as preparations for medical treatments, in particular, antibodies and derivatives being monoclonal antibodies, bispecific antibodies, multispecific antibodies, antibody fragments, single-chain variable fragments, di-scFv or light and heavy chains of antibodies for medical purposes, bifunctional or multifunctional proteins being T-cell engagers or NK cell engagers for medical purposes with binding affinity to immune cells, in particular NK cells, and other reagents for the diagnosis, prevention, monitoring and treatment of diseases, in particular cancers, infectious diseases, inflammatory diseases, and other immune pathologies

Chemical or biotechnological products for industry and science, namely, polypeptides and proteins; biological preparations, in particular antibodies in the nature of monoclonal antibodies, bispecific antibodies or multifunctional antibodies, antibody derivatives in the nature of antibody fragments, single-chain variable fragments, di-scFv, light and heavy chains of antibodies, binding proteins and peptides having a binding affinity to immune cells in the nature of T-cell engagers or NK-cell engagers, for laboratory and experimental purposes, in particular for conducting experimental tests other than for medical use; Biochemicals, namely, polypeptides for in vitro research use

Scientific and technological services, namely, research and development in scientific and medical matters, in particular in the field of immunotherapy; scientific and technological services, namely, scientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory research, analysis, evaluation, development and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodies, antibody derivatives, proteins, or other agents for activating or modulating natural and adaptive immunity

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 17, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 8, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 8, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2021 NWOS
NEW APPLICATION ENTERED
Oct 25, 2021 NWAP